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early host immune responses againstMycobacteriummassiliense
infection
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ABSTRACT
Mycobacterium massiliense (M. mass), belonging to the
M. abscessus complex, is a rapidly growing mycobacterium that is
known to cause tuberculous-like lesions in humans. To better
understand the interaction between host cells and M. mass, we
used a recently developed in vitro model of early granuloma-like cell
aggregates composed of human peripheral blood mononuclear cells
(PBMCs). PBMCs formed granuloma-like, small and rounded cell
aggregates when infected by live M. mass. Microscopic examination
showed monocytes and macrophages surrounded by lymphocytes,
which resembled cell aggregation induced byM. tuberculosis (M. tb).
M. mass-infected PBMCs exhibited higher expression levels of HLA-
DR, CD86 and CD80 on macrophages, and a significant decrease in
the populations of CD4+ and CD8+ T cells. Interestingly, low doses of
M. mass were sufficient to infect PBMCs, while active host cell death
was gradually induced with highly increased bacterial loads,
reflecting host destruction and dissemination of virulent rapid-
growing mycobacteria (RGM). Collectively, this in vitro model of
M. mass infection improves our understanding of the interplay of host
immune cells with mycobacteria, and may be useful for developing
therapeutics to control bacterial pathogenesis.
KEYWORDS:Mycobacteriummassiliense, Host immune responses,
In vitro granuloma, PBMC
INTRODUCTION
Mycobacteriaum abscessus (M. abscessus) complex are rapidly
growing mycobacteria (RGM) that are important human pathogens
responsible for a wide spectrum of soft tissue infections and
disseminated infection in immunocompromised patients (Prevots
and Marras, 2015). M. abscessus complex are closely involved in
respiratory infection, especially in patients with cystic fibrosis or
chronic bronchiectasis (Olivier et al., 2003). M. abscessus complex
comprises three genetically related species: M. abscessus (sensu
stricto), M. massiliense, and M. bolletii (Zelazny et al., 2009). In a
clinical study, M. abscessus was found to acquire inducible
resistance to clarithromycin more commonly than M. massiliense
(M. mass), and treatment response rates to antibiotic therapy
including clarithromycin were much higher in patients withM.mass
than in those with M. abscessus (Koh et al., 2011).
M. mass is known to exhibit either smooth or rough colony
morphologies on solid media (Kim et al., 2012, 2013) depending on
specific mutations of genes associated with the synthesis of
glycopeptidolipid (GPL) (Kim et al., 2013; Howard et al., 2006).
The rough strains produce cord-like structures involved in in vivo
pathogenesis and immune evasion (Bernut et al., 2014).
Furthermore, in mice, rough variants were shown to be
hypervirulent when administrated intravenously compared to the
smooth wild-type (Catherinot et al., 2007). Thus, each colony
morphotype of mycobacteria exhibits different interactions between
the bacteria and host immune system.
Similar to virulent mycobacteria like M. tuberculosis (M. tb) and
the M. avium complex (MAC), M. mass also causes inflammatory
diseases, ranging from localized abscess to disseminated lesion
(Shang et al., 2011; Martins de Sousa et al., 2010). In a mouse
model, M. mass induced granulomatous responses involving the
activation of macrophages, dendritic cells, and natural killer cells in
host immune cells (Martins de Sousa et al., 2010).M. abscessus- or
M. mass-infected macrophages secrete inflammatory cytokines and
chemokines, such as TNF-α, IL-12, IL-6 and MCP-1, which recruit
and activate various immune cells (Martins de Sousa et al., 2010;
Kim et al., 2014a; Shin et al., 2008). Recruitment and activation of
mononuclear cells and T lymphocytes leads to early granuloma
formation in infection sites, like the lung, spleen and liver.
Granuloma formation is a major defense response against
mycobacterial infection to prevent dissemination. Granulomas are
initially composed of activated macrophages including epithelioid
cells, surrounded by T and B lymphocytes (Silva Miranda et al.,
2012). This progresses into a mature granuloma with fibrosis by
fibroblast recruitment, or caseous necrosis later. Recently, in vitro
models of granuloma using PBMC were developed to study the
molecular interactions between host immune cells and mycobacteria
(Puissegur et al., 2004; Birkness et al., 2007). These in vitro
granuloma-like cell aggregates can be induced by infection of human
or bovine PBMCs with live mycobacteria or mycobacterial antigen
(e.g. PPD-coated sepharose beads). In vitromycobacterial granuloma
was characterized with the progressive recruitment of macrophages
and T lymphocytes around the live bacilli, and they differentiated into
epithelioid cells (EC) and multinucleated giant cells (MGC) within
about 7 days after infection (Puissegur et al., 2004). Although in vitro
granulomas do not exhibit some features of granuloma maturation,
like fibrosis or caseousness, this model mimics early host immune
responses against M. tb infection very well.
In this study, we first report that infection of human PBMC
with M. mass induces the formation of granuloma-like cellularReceived 28 April 2016; Accepted 28 June 2016
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aggregates and these aggregates feature characteristics of early
interactions between host cells and RGM. By using this model, we
could examine early immune responses against M. mass, and
understand the bacterial pathogenesis of smooth or rough strains,
including the survival and dissemination of virulent RGM at early
stages of infection.
RESULTS
Formation of granuloma-like cellular aggregates by infection
of human PBMC with Mycobacterium massiliense
When fresh PBMC (1×106 cells/well) were infected with
mycobacteria (103-104 CFU/well), the cells clustered to form
granuloma-like aggregates. To analyze not only structural changes
but also immunological changes and differentiation of macrophage
over the course of infection progression, we incubated PBMC
without growth factors for 4 days and then infected them with
mycobacteria. Formation of granuloma-like cellular aggregates was
observed at 4 days post-infection (Fig. 1A). However, a low number
of cellular aggregates with small size were examined at 4 days, and
these became larger as incubation progressed. While 104 colony-
forming units (CFU) of M. tb H37Ra stably induced cellular
aggregation, the same inoculum of M. mass induced such rapid
bacterial growth that we could not keep the cellular aggregates stable
for more than 7 days post-infection. Instead, 103 CFU of M. mass
was shown to form more stable aggregation, lasting more than
7 days (Fig. 1B). Microscopic examination showed that the cellular
structure of the aggregates consisted of active and epitheloid
macrophages surrounded by T lymphocytes. M. mass infection
also induced the formation of foamy macrophages, a distinct
characteristic of granulomas associated with virulent mycobacteria
(Peyron et al., 2008). This structure has close similarities to an early
form of granuloma. AFB staining of infected cells showed that the
mycobacteria were phagocytosed or attached to macrophages.
However, multinucleated cells (MC) and multinucleated giant cells
(MGC) were sparsely observed inM. mass-infected PBMCs at very
low frequencies (<1 of 1×105), unlike virulent M. tb-infected
granulomas (Fig. 1C) (Lay et al., 2007). Confocal microscopic
examination revealed that the inner cells of the aggregates were
positive for CD68, a macrophage-specific marker, and the outer
cells were positive for CD3, a T cell marker (Fig. 1D). Collectively,
these observations indicate that the cellular structure of the
aggregates mimics early granulomas.
Structural changes of granuloma-like cellular aggregates
afterM. mass infection
With continued incubation, infected cell aggregates became more
common and more clearly visible. M. tb H37Ra infection induced
larger and more compact aggregates at 7 days compared to 4 days
post-infection (average size=242.8 µm, s.d.=58.4 µm) (Fig. 2A).
AFB stain showed an increased number ofM. tbH37Ra associated
with macrophages at 7 days post-infection. When PBMC were
infected by M. mass, not only intracellular but also extracellular
bacterial growth was observed. To determine the main source of
extracellular bacteria, we investigated the number of cell-
associated or extracellular M. mass during infection. Cell-
associated bacteria comprised most of total bacterial load and
the percentage of extracellular bacteria was very low until 4 days
post-infection. At 7 days, extracellular bacteria rapidly increased,
accompanying cell lysis response, and showed the similar
numbers to that of cell-associated bacteria (Fig. S1A,B). These
results reveal that most of extracellular bacteria may come from
infected cells after cell necrosis. At 7 days post-infection,
extracellular rough isolate of M. mass (M. mass R) was shown
to form cord-like structures, which are known to form in cultures
of rough isolates ofM. abscessus complex and other mycobacteria
(Fig. 2B) (Jönsson et al., 2013a,b). The cord-like structure was
Fig. 1. Formation of granuloma-like cellular aggregates by infection of human PBMCs with M. mass. (A) Microscopic examination of granuloma-like
aggregates infected with M. mass at 1, 4 and 7 days after infection. Scale bar: 200 µm. Arrow indicates cellular aggregate. (B) Microscopic examination of
granuloma-like aggregates infected with M. tb H37Ra, M. mass R and M. mass CIP at 7 days after infection. NI, non-infected. Scale bar: 400 µm. (C) Cell
populations in M. mass-infected cellular aggregates at 7 days after infection. Giemsa and AFB staining show infected PBMCs are composed of activated
macrophages (Mf), lymphocytes (Ly), epitheloid cells (EC), foamy macrophages (FM), multinucleated cells (MC) having 2 nuclei, multinucleated giant cells
(MGC) having several nuclei. Scale bar: 50 µm. (D) Confocal microscopy examination of a M. mass CIP-induced granuloma-like aggregates stained with
monoclonal antibodies against CD68 (macrophages, blue) and CD3 (T cells, red). Scale bar: 50 µm.
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found to be surrounded by host cells and induce aggregation
of cells and extracellular bacteria (average size=1100 µm,
s.d.=424.3 µm). M. mass strain CIP 108297 (M. mass CIP) also
revealed excessive extracellular growth at 7 days, and attachment
to host cell aggregates (average size=328.8 µm, s.d.=49.7 µm).
Because the aggregates were surrounded by bacteria, they showed
rough surface morphology under microscopy (Fig. 2C). These
results indicate that virulent RGM, such asM. abscessus complex,
may have extracellular growth or biofilm formation in susceptible
hosts and interact with host cells in different ways from
intracellular bacteria.
Expression of cell surface antigens on macrophages inM.
mass-infected PBMC
To characterize the differentiation and activation of macrophages
afterM. mass infection, we investigated the expression levels of cell
surface markers (CD68, CD206, CD163, HLA-DR, CD86 and
CD80) on macrophages by FACS analysis. At 1 day post-infection,
there was no significant difference in the expression levels of
cellular markers on macrophages among the groups. At 7 days post-
infection, M. mass-infected cells showed lower expression of
CD68 (pan-macrophage marker present on lysosomal-associated
membrane proteins), CD206 (mannose receptor) and CD163
Fig. 2. Structural characteristics of granuloma-like aggregates afterM. mass infection. AFB and Giemsa staining of the cellular aggregates at 4 and 7 days
post-infection (dpi) with (A) M. tb H37Ra, (B) M. mass R and (C) M. mass CIP. Enlarged view of mycobacteria within macrophages. (D) NI, non-infected cells
(×200). Scale bar: 100 µm. Arrow indicates mycobacteria.
Fig. 3. Expression levels of cell surface antigens onmacrophages inM. mass-infected PBMCs. Infected and uninfected samples were harvested at 7 days
post-infection and analyzed for expression of surfacemarkers onmacrophages by flow cytometry. (A) The expression levels of CD68, CD163 andCD206. (B) The
expression levels of HLA-DR, CD86 and CD80. H37Ra, M. tb H37Ra; MR, M. mass R; CIP, M. mass CIP; NI, non-infected. One representative data set is
shown out of eight unrelated healthy donors. Results are shown as the mean±s.d. from duplicated samples. *P<0.05; **P<0.01; ***P<0.001 by one-way ANOVA
with Bonferroni’s post-test.
1120
RESEARCH ARTICLE Biology Open (2016) 5, 1118-1127 doi:10.1242/bio.019315
B
io
lo
g
y
O
p
en
(scavenger receptor) than non-infected cells (Fig. 3A). These results
show that M. mass infection prevents the expression of anti-
inflammatory markers but induces macrophage differentiation at
early infection stages. The expression levels of inflammatory
markers HLA-DR (MHC class II cell surface receptor), CD86 and
CD80 (costimulatory signals for T cell activation) were highest on
macrophages infected by M. mass R (Fig. 3B). In particular, the
expression level of HLA-DR was significantly higher in M. mass-
infected cells thanM. tb-infected cells. At 4 days post-infection, the
expression patterns of cellular markers on macrophages were similar
to those at 7 days after infection. However, because cellular
aggregates were small in number and induced a weak immune
response at 4 days, we could not observe any significant difference
of the expression levels between infected samples and uninfected
control (data not shown). Collectively,M.mass infection was shown
to induce surface markers related to adaptive immunity activating
specific T cells and differentiate macrophages to inflammatory type
rather than anti-inflammatory type at early stages of granuloma
formation.
Changes in T cell population inM. mass-infected PBMC
We investigated the population of T lymphocytes in PBMC after
mycobacterial infection (Fig. 4A). M. tb infection is known to cause
depletion of CD4+ T cells (Wu et al., 2009; Kapoor et al., 2013). Our
experimental model also showed similar results. While there was no
significant difference between each group at 4 days post-infection, a
decrease in the population of CD3+CD4+ T cells was detected in
PBMC infected by M. tb H37Ra at 7 days post-infection (P=0.048,
M. tb-infected versus uninfected). M. mass infection also induced
significant decrease in CD3+CD4+T cells (Fig. 4B).While therewas
no change in the population of CD3+CD8+ T cells inM. tb infection,
a significant decreasewas observed inM.mass-infected cells with the
largest decreasewithM.massCIP infection.M. tb infection is known
to cause increase in CD4+CD25+ regulatory T cells (Kapoor et al.,
2013). Our result also showed M. tb H37Ra infection increases the
number of CD4+CD25+ T cells compared to uninfected control.
However, M. mass infection did not induce a significant change in
population of CD4+CD25+ T cells. In addition, we discriminated
between granuloma-involved T cells and surrounding T cells, and
Fig. 4. Changes in the T cell populations of PBMC after M. mass infection. At 7 days after infection, infected or uninfected PBMCs were analyzed for
expression of T cell markers (CD3, CD4, CD8 and CD25) by flow cytometry. (A) Gating strategy for flow cytometry analysis of T lymphocytes. (B) CD3+CD4+,
CD3+CD8+ and CD4+CD25+ T cells population in PBMCs. (C) The expression levels of T cell surface antigen CD3measured by MFI. H37Ra,M. tbH37Ra; MR,
M. mass R; CIP,M. mass CIP; NI, non-infected. One representative data set is shown out of eight unrelated healthy donors. Results are shown as the mean±s.d.
from duplicated samples. **P<0.01; ***P<0.001 compared to non-infected group by one-way ANOVA with Bonferroni’s post-test.
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analyzed each cell population (Fig. S2A,B). M. mass infection
induced a decrease in CD4+ T cells and CD8+ T cells in not only
granuloma-involved cells but also surrounding cells. We did not
observe a significant change in CD4+CD25+ regulatory T cells by
M. mass infection. However, M. tb H37Ra infection increased
CD4+CD25+ regulatory T cells in granuloma-involved cells, but did
not induce similar response in surrounding T cells. The decline of
CD4+ T cells and CD8+ T cells by mycobacterial infection was more
severe in surrounding cells. Thus, in our model, asM. mass infection
progresses, CD3 expression levels in PBMC were reduced,
accompanying increase in bacterial burden (Fig. 4C). These results
indicate thatM. mass causes a depletion of host T cells at early stages
of infection to enable bacteria to effectively evade host protective
responses, including adaptive immunity.
Inflammatory cytokine secretions inM.mass-infected PBMC
To compare the secretion of inflammatory cytokines in response to
various mycobacteria, 1×106 PBMC were infected with the same
inoculum of 1×104 CFU/well. The culture supernatants were
harvested at 1-7 days post-infection and levels of cytokines were
determined using ELISA (Fig. 5). The secretion of inflammatory
cytokines TNF-α, IL-1β, IL-6 and IFN-γ were induced in human
PBMC from 1 day after infection. The levels of TNF-α, IL-6
and IFN-γ tended to increase gradually as infection progressed.
M. tb-infected cells secreted significantly higher levels of
inflammatory cytokines than uninfected cells at 3 or 7 days post-
infection (P<0.001). M. mass led to an increase in TNF-α level
compared to uninfected samples 3 days post-infection (P<0.05).
M. mass R induced more TNF-α secretion than M. mass CIP did.
IL-1β was rarely detected in PBMC infected with M. mass at low
multiplicity of infection (MOI). IFN-γ secretion gradually increased
during infection and was detected inM. mass-infected PBMC 7 days
post-infection. Notably, although infected PBMC contained much
higher bacillary loads ofM.mass thanM. tb,M.mass-infected PBMC
induced lower levels of inflammatory cytokines than M. tb-infected
cells. These results indicate that M. mass induces pro-inflammatory
cytokines but may modulate inflammation at early stages of infection
even though growing rapidly. These responses may associate with
impaired maturation of M. mass-induced granuloma.
Cell death in human PBMC induced by M. mass infection
Virulent mycobacteria are known to induce host cell lysis after
infection. Upon microscopic examination, we observed that
M. mass also induces death of infected cells with a high burden
of intracellular bacteria (Fig. 6A). AFB staining showed that
M. mass grows actively in infected macrophages and triggers cell
membrane rupture. M. mass exhibited more rapid intracellular
growth and stronger cytolytic activity than M. tb H37Ra. To
determine whether M. mass directly induces cell necrosis or
apoptosis, infected PBMCs were isolated and assessed by Annexin
V and 7-AAD staining (Fig. 6B). At 4 days post-infection, we
observed ruptured cells with a high burden of M. mass upon
microscopic examination, but double staining results did not show
significant differences with cell death between M. mass-infected
and uninfected cells (data not shown). At 7 days, over 20% of
M. mass-infected cells showed secondary necrotic features
(Annexin V-positive and 7-AAD-positive) compared to about
10% of uninfected cells (Fig. 6C). In addition, the 7-AAD-positive
cell population was twofold higher in M. mass-infected cells than
M. tb H37Ra-infected or uninfected cells (Fig. 6D). Furthermore,
Fig. 5. Inflammatory cytokine secretions of human PBMC infected with M. mass. Culture supernatants from different groups were harvested at 1, 3 and
7 days post-infection. Mean concentrations of secreted TNF-α, IL-1β, IL-6 and IFN-γ were measured by ELISA. Ra,M. tb H37Ra; MR,M. mass R; CIP,M. mass
CIP; NI, non-infected. One representative data set is shown out of eight unrelated healthy donors. Results are shown as the mean±s.d. from duplicated samples.
*P<0.05; **P<0.01; ***P<0.001 compared to M. tb H37Ra-infected group or NI group by two way ANOVA with Bonferroni’s post-test.
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the live cell population was significantly lower in M. mass-infected
samples than uninfected samples. These results suggest that
M. mass grows to a critical threshold and then triggers the death
of host cells with more necrotic features than apoptosis. This may
have detrimental effects to the host.
DISCUSSION
M. abscessus complex is the most pathogenic RGM species,
causing a wide spectrum of inflammatory diseases, including
chronic lung disease, and skin and soft tissue abscesses. Host
responses against M. abscessus infection mainly comprise cell-
mediated immunity (CMI) (Kapoor et al., 2013). CMI responses
include activation of phagocytosis, antigen presentation and
antigen-specific cytotoxic T cell responses. These responses
stimulate cells to secrete a variety of cytokines and chemokines
(e.g. IFN-γ, IL-12, TNF-α, IL-8) that induce migration and close
interaction of immune cells, leading to granuloma formation (Silva
Miranda et al., 2012). Therefore, a study of mycobacteria-induced
granuloma can provide us with an understanding of the molecular
interactions between host immune cells and mycobacteria.
To study granulomatous response to mycobacterial infection,
animal models such as mouse, guinea pig, rabbit and monkey are
often used. Animal models may reproduce several of the processes
occurring in humans, but some differences are often observed
(Guirado and Schlesinger, 2013). For example, while mouse models
are inexpensive and their genes are easy to manipulate, they do not
show caseous necrosis, granuloma structure and organization. To
fill this gap, several recent studies have reported models of in vitro
Fig. 6. Cell death of human PBMCs induced byM. mass infection. To determinate cell death byM. mass infection, harvested cells from different groups were
stained by Giemsa staining for microscopy and stained with Annexin V and 7-AAD for analysis by flow cytometry. (A) Microscopic examination of macrophage cell
death with intracellular growth of M. mass CIP at 7 days post-infection, by using AFB-Giemsa staining. Scale bar: 25 µm. (B) Flow cytometry analysis of PBMC
stained with Annexin V (AV) and 7-AADat 7 days post-infection. The numbers indicate the percentage of cells in each quadrant. Lower left, AV–/7-AAD–, live cells;
lower right, AV+/7-AAD–, apoptotic cells; upper left, AV–/7-AAD+, necrotic cells; upper right, AV+/7-AAD+, late apoptotic or secondary necrotic cells. (C) Bar
graph representing the mean proportion of live, apoptotic, necrotic or late apoptotic cells undergoing secondary necrosis analyzed in B. (D) Bar graph
representing themean proportion of 7-AAD+ cells from each group. H37Ra,M. tbH37Ra; MR,M.massR; CIP,M.massCIP; NI, non-infected. One representative
data set is shown out of eight unrelated healthy donors. Results are shown as the mean±s.d. from duplicated samples. **P<0.01; ***P<0.001 compared to non-
infected group by ANOVA with Bonferroni’s post-test.
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granuloma formation using PBMCs treated with mycobacterial
antigen-coated beads or infected with mycobacteria (Puissegur
et al., 2004; Birkness et al., 2007). This model has some
disadvantages inherent to in vitro models, but it has increased our
knowledge about early cell differentiation and interactions between
host cell and mycobacteria within the granuloma (Peyron et al.,
2008; Guirado and Schlesinger, 2013).
In this study, we showed that M. mass, a species ofM. abscessus
complex, induces formation of in vitro granuloma-like aggregates in
PBMCs. In previous studies, when PBMCs (1×106 cells/well) were
incubated with viableM. tb orM. bovis at MOI of 1:0.01 or higher,
in vitro granulomas were obtained and kept stable for 14 days post-
infection (Puissegur et al., 2004; Peyron et al., 2008). However,
using RGM-likeM. smegmatis, a low MOI (<1:0.01) was sufficient
for inducing in vitro granuloma formation (Peyron et al., 2008).
Because M. mass is also rapid-growing, we used a low MOI of
1:0.001 and could keep cellular aggregates stable for 7 days post-
infection.
Granuloma-like cellular aggregates were first observed 4 days
post-infection. However, cellular aggregates were small in the
number and size, and immunological changes were not obvious at
that point. At 7 days post-infection, we observed larger cellular
aggregates, which were attached by large amounts of extracellular
bacteria. When we analyzed the amounts of extracellular bacteria
and cell-associated bacteria during infection, most of the
extracellular bacteria appeared to have escaped from infected
macrophages after cell necrosis. A previous study also reported that
M. abscessus escapes from infected macrophages after cell death
and develops extracellular growth leading to cord formation (Bernut
et al., 2014). This phenomenon is different from that of M. tb-
induced in vitro granulomas, which showed granuloma maturation
with limited extracellular bacterial growth over infection
progression (Jönsson et al., 2013a; Kapoor et al., 2013). While
M. mass CIP was examined intracellularly and extracellularly
among cell aggregates, M. mass R induced extracellular cord
formation surrounded by host cell aggregates. Cord formation is
characteristic of M. tb and other mycobacteria infection (Darzins
and Fahr, 1956). Rough strains of M. abscessus complex are also
known to induce cord formation, which are involved in virulence
and survival of bacteria in the host environment (Bernut et al., 2014;
Sánchez-Chardi et al., 2011). A study using a zebrafish model
revealed rough strains ofM. abscessus form cord-like aggregates in
vivo and could not be phagocytosed by host cells (Bernut et al.,
2014). Similarly, in our model, a high burden of extracellular
bacteria and cord structure seem to have detrimental roles to host
cells, and may affect reduced T cell survival. In another study, when
human PBMCs were infected with a high dose of M. abscessus,
bacterial cord formations were found to be entrapped by monocytes
and lymphocytes, aggregated onto DNA extracellular traps at day 1
(Jönsson et al., 2013b). Our results also show a similar interaction
between PBMCs and M. mass R and confirm this mechanism of
mycobacterial evasion of phagocytosis, although host cells were
infected with a lower dose of bacteria.
M. mass is known to induce granulomatous reaction and secretion
of inflammatory cytokines in mice and macrophages (Martins de
Sousa et al., 2010; Kim et al., 2014a). In our model, inflammatory
cytokine secretion was also examined in PBMC infected with
M. mass. However, because we infected the cells with M. mass at
very low MOI (0.001), the levels of cytokine secretion gradually
increased and seem to be lower compared to a previous study using
high MOI (Jönsson et al., 2013b). Interestingly, although M. mass
show intracellular and extracellular growth with infection
progression, M. mass-infected PBMCs were shown to induce
lower levels of inflammatory cytokines compared to cells infected
with M. tb H37Ra. We did not use virulent M. tb strains, like
H37Rv, and therefore did not compare the level of cytokines
induced byM. mass toM. tb. However, a previous study comparing
the effect of H37Ra with H37Rv infection on chemokine and
cytokine expression in mouse peritoneal macrophages, H37Ra was
found to preferentially induce higher levels of mRNAs of IFN-
inducible protein (IP-10), lymphotactin, macrophage inflammatory
protein-3 (MIP-3), and fractalkine, but there were no significant
differences in genes encoding pro-inflammatory cytokines (TNF-α,
IL-1β, IL-12 and IL-6) (Freeman et al., 2006). Another study using
mouse peritoneal macrophages also showed no significant
differences in IL-1β, IL-10, IL-12p40 and IL-12p70 secretion
between M. tb H37Rv and H37Ra infection (Singh and Goyal,
2013). From these published results we can infer that inflammatory
cytokines are induced at lower levels in M. mass than M. tb
infection, suggesting thatM. massmay have protective mechanisms
modulating early inflammatory responses despite the high burden of
bacteria. Granuloma disorganization can be caused by impairing
pro-inflammatory cytokine production during granuloma formation
(Silva Miranda et al., 2012). The modulation of early inflammatory
cytokine secretion byM. mass may impair maturation of functional
granuloma and facilitate dissemination of bacteria. Such responses
may be affected by some components produced in M. mass. For
example, GPL, a cell wall component ofM. abscessus, was reported
to block induction of human macrophage TNF-α by preventing
interaction between cell wall antigen with TLR2 (Rhoades et al.,
2009). To definitively elucidate the immunomodulatory strategies
of M. abscessus complex, we need to further study the functions of
specific antigens and bacterial structures, like biofilm and cord
formation, in evading host immune responses.
M. tb infection was reported to hamper differentiation of human
monocyte to macrophage, decreasing CD68 and CD36 (scavenger
receptor) expression (Castaño et al., 2011). We also observed lower
expression levels of CD68, CD206 and CD163 on monocytes of
PBMC infected by M. mass. These results indicate that M. mass
prevents monocyte differentiation into macrophages and may
inhibit the activation of immune cells. HLA-DR and CD86 are
known to performmajor functions of antigen presentation and T cell
activation (Effros et al., 1983; Jeannin et al., 2000). While HLA-DR
and CD86 expression were also decreased in human monocytes
infected by virulent M. tb H37Rv, the expression levels were
increased in M. mass-infected cells. These results indicate that
adaptive immunity associated with specific T cell activation is
central to protective responses against M. mass (Kim et al., 2014b).
In a clinical study,M. tb infection was found to cause CD4+ T cell
lymphocytopenia without changing levels of CD8+ T cells (Wu
et al., 2009). The decrease in CD4+ T cells was also manifested in
an in vitro granuloma model using virulent M. tb strains (Kapoor
et al., 2013). Interestingly, in our study, avirulent M. tb H37Ra
infection also showed a decrease in the number of CD4+ T cells. In
contrast, M. mass-induced in vitro granulomas exhibited a decrease
in not only CD4+, but also CD8+ T cells. This response may be
caused by extracellular bacterial aggregation and cord structure,
which may inhibit macrophage-T cell interaction and T cell
survival, and also cause toxicity or damage to host cells. A
previous study also reported that extracellular M. abscessus,
forming cord structure, impairs host immune responses such as
phagocytosis and granuloma formation, and develops active growth
accompanying host cell depletion (Bernut et al., 2014). Such a
depletion of effective T cells may be early pathogenic responses
1124
RESEARCH ARTICLE Biology Open (2016) 5, 1118-1127 doi:10.1242/bio.019315
B
io
lo
g
y
O
p
en
induced by M. mass infection and reflect the importance of
maintaining T cell populations for host protection. A previous study
using a mouse model showed that active T cell recruitment occurs
during the early stages of M. abscessus infection and that Cd3ε−/−
mice were severely impaired in their ability to control bacteria
growth in both the liver and the spleen (Rottman et al., 2007).
Another study using IFN-γ knockout mice also showed early influx
of IFN-γ and CD4+ T cells is important for clearance of
M. abscessus infection (Ordway et al., 2008). These data align
with the frequent occurrence of M. abscessus in patients with
immunodeficiency or pre-existing lesions of the respiratory tract,
like cystic fibrosis (Cullen et al., 2000).
Virulent M. tb is known to induce cell death of monocytes and
macrophages through phagosomal rupture (Simeone et al., 2012).
It thus escapes host defense mechanisms and disseminates to
extracellular regions or to other cells. These responses are mediated
by mycobacterial secretory systems (ESX-1) and virulent antigen,
ESAT-6 (Guinn et al., 2004; Gao et al., 2004). We also observed
severe cell necrosis over time in PBMCs infected byM. mass. While
M. tb causes cell rupture by secreting virulent factor with
membrane-lysing properties, M. mass may trigger membrane
damage by intracellular overgrowth and aggregation of
phagocytosed bacilli. Interestingly, extracellular cord formation
was observed in PBMCs infected with M. mass R and found to
affect necrotic cell death, although they are not phagocytosed. These
results are similar to a previous in vivo study using zebrafish, that
demonstrated that released M. abscessus Rough variant from
apoptotic macrophages induces abscess following extracellular cord
formation (Bernut et al., 2014). However, because M. abscessus
complex secretory antigens and virulent factors have not yet been
defined in detail, more studies using genetic or proteomic
approaches are required to elucidate the mechanisms for evading
immune systems and damaging host cells.
This in vitro granuloma model of M. mass infection has some
limitations.M. tb, a virulent slow-growing mycobacterium, induces
granuloma formation and goes into dormancy by adapting to the
host environment (Kapoor et al., 2013). In this M. tb-induced
in vitro granuloma model, dormant M. tb can be reactivated by
adding anti-TNF-α monoclonal antibody (Kapoor et al., 2013).
Although infection with M. mass, a virulent RGM, also induces
in vitro granuloma-like cell aggregates with inflammatory
responses, it did not enter dormancy within the granuloma.
Furthermore, mycobacterial infection induces inflammatory
responses followed by suppressive mediators to balance immune
responses during granuloma maturation (Arkhipov et al., 2013).
However, it was difficult to examine the balance between pro- and
anti-inflammatory responses in the in vitro granulomas induced by
M. mass infection. In addition, while bacterial loads ofM. masswas
shown to gradually decrease in C57BL/6 and BALB/c mice, the
in vitro model showed an increase in intracellular and extracellular
bacteria, reflecting the incomplete capability of the in vitromodel to
control the growth ofM. mass (Shang et al., 2011; Martins de Sousa
et al., 2010). In this regard, extracellular bacterial growth may
induce nonspecific responses, unlike the in vivo circumstance.
However, recent studies reported extracellular M. abscessus also
play a role in bacterial pathogenesis in patient and animal model
(Bernut et al., 2014; Qvist et al., 2015).
In summary, although M. mass-induced in vitro granulomas
could not completely reproduce responses during granuloma
maturation, it provides basic information about host inflammatory
responses during early stages of infection. Furthermore, T cell
depletion and host cell death caused by intracellular and
extracellular expansion of M. mass, confirm that adaptive
immunity is important for host protection. This is substantiated by
the fact that abscesses with bacterial colonization are often observed
in patients with immune disorders. Thus, this in vitro granuloma
model provides us with insight into bacterial pathogenesis and
the interplay between host and mycobacteria. Such applications
will help to develop effective therapeutic strategies against
mycobacterial infection.
MATERIALS AND METHODS
Human blood samples and cell culture
Human blood samples were collected from seven BCG-vaccinated, healthy
Korean volunteers between the ages of 27 and 40 (4 males and 3 female). In
Korea, BCG vaccination is compulsory for children aged 0-1 years old.
Blood collection and processing was performed according to the principles
established by the Seoul National University Hospital Institutional Review
Board (IRB), which approved our use of blood samples (Approval Number
1402-104-560). As the procedure approved by the IRB, each volunteer
signed a written consent to participate to the trial according to ethical
guidelines stated in the Declaration of Helsinki. Collected PBMCs were
separated from whole blood by density gradient centrifugation using
standard protocol with Ficoll-Paque Plus (GE Healthcare, Piscataway
Township, NJ, USA). Purified PBMCs were cultured in RPMI containing
10% heat-inactivated pooled human AB serum (Sigma-Aldrich, St. Louis,
MO, USA).
Bacterial strains and growth conditions
M. tbH37Ra (strain ATCC 25177) was obtained from the ATCC (American
Type Culture Collection, VA, USA). M. mass strain CIP 108297 (M. mass
CIP) was obtained from CIP (Collection of Institut Pasteur, Paris, France).
A rough isolate ofM.mass (M.massR) was kindly provided byDr B. J. Kim
(Seoul National University, Seoul, South Korea).M. tbH37Ra andM. mass
were cultured in Middlebrook 7H9 medium (BD Biosciences, Franklin
Lakes, NJ, USA) supplemented with 10% OADC (BD Biosciences), 0.2%
glycerol and 0.05% Tween 80 (Sigma-Aldrich). For all experiments,
mycobacteria were cultured in late log phase and a portion of heavy
aggregates was excluded by centrifugation. Then, collected mycobacteria
were homogenized and stored at −70°C. Representative bacterial vials were
thawed and the number of colony-forming units (CFU) viable on
Middlebrook 7H10 agar plates (BD Biosciences) were counted. Then,
mycobacteria were suspended in RPMI medium containing 10% human
sera, and used for infection.
PBMC infection for the formation of cellular aggregates
Granuloma-like cellular aggregates formation was induced as previously
described (Birkness et al., 2007). Freshly isolated 1×106 PBMCs were
plated in 24-well culture plates (Corning, Corning, NY, USA) and
differentiated for 4 days in RPMI containing 10% human serum. To
induce granulomatous reaction, 1×103 or 1×104 CFU of mycobacteria was
then added to each well, and infected PBMCs were cultured at 37°C in a 5%
CO2 atmosphere for 10 days. To detect cytokine production of host cells,
1×104 CFU was used. Formation of granuloma-like cellular aggregates was
examined every day under microscopy.
Histological staining and microscopic examinations
Granuloma-like cellular aggregates were harvested and plated onto slide
glasses by using a cytospin (Thermo Fisher, Waltham,MA, USA). The cells
on slide glasses were fixed for 30 min in 4% PFA solution at room
temperature and, to examine lipid bodies in cells, stained for 15 min with
15% Oil Red-O (Sigma-Aldrich) in isopropanol. To examine mycobacteria
within infected PBMCs, an acid-fast bacilli (AFB) stain kit (BD
Biosciences) was used and staining was performed according to the
manufacturer’s instructions. The slides were then stained for 10 min with
Giemsa staining solution (Sigma-Aldrich). For fluorescence analysis, fixed
granuloma cells were blocked with 1% BSA in PBS for 1 h and then stained
with phycoerythrin (PE)-conjugated anti-human CD68 monoclonal
antibody and allophycocyanin (APC)-conjugated anti-human CD3
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monoclonal antibody (BD Biosciences) for 2 h. Stained cells were then
washed and observed under a fluorescence microscope (Olympus, Center
Valley, PA, USA) and confocal microscope A1 (Nikon, Minato, Tokyo,
Japan).
Bacterial counts
To measure bacterial number of cell-associated M. mass, after removing
culture supernatants from each well, infected cells were lysed in 0.1% Triton
X-100, and 10-fold serial dilutions of lysed cells were plated on Luria-
Bertani (LB) agar. After 4 days, the number of colony was counted and total
bacterial numbers were calculated as log10 colony forming units (CFU).
The number of extracellular bacteria was measured by recovering viable
M. mass from culture supernatants of each sample.
Cytokine analysis
For cytokine analysis, the supernatants of each well were harvested at 1, 3
and 7 days post-infection, and stored at −80°C until use. The levels of
inflammatory cytokines (TNF-α, IFN-γ, IL-6 and IL-1β) were quantified
using an enzyme-linked immunosorbent assay (ELISA) kit (Roche, Basel,
Switzerland). The assays are performed according to the manufacturer’s
instructions.
Flow cytometric analysis of surface antigens on macrophages
For the analysis of cell surface antigens on macrophages, PBMCs were
collected at 7 days post-infection. Surface antigen staining was performed
with combinations of peridinum chlorophyll (PerCP)-Cy5.5-conjugated
mAb against CD14 (61D3), eFluor 450-conjugated mAb against CD11b
(M1/70), PE-conjugated mAb against CD163 (eBioGHl/61), PerCP-eFluor
710-conjugated mAb against CD80 (2D10.4), PE-conjugated mAb against
CD86 (IT2.2), APC-conjugatedmAb against HLA-DR (LN3) (eBioscience,
San Diego, CA, USA), APC-conjugated mAb against CD206 (19.2) (BD
Biosciences), and fluorescein isothiocyanate (FITC)-conjugated mAb
against CD68 (KP1) (Santa Cruz, Dallas, TX, USA). The expression level
of CD68 was analyzed on monocyte-associated surface antigens CD14+
and CD11b+ cells, and the expression levels of CD206, CD163, HLA-DR,
CD86 and CD80 were analyzed on macrophage-associated surface antigens
CD68+ and CD11b+ cells. The expression levels are presented as median
fluorescence intensity (MFI). The fluorescence levels on the stained cells
were measured using BD LSR Fortessa and the data were analyzed using
FlowJo software (BD Biosciences).
Analysis of T cell population
For staining surface markers of T lymphocytes, the combination of PE-
conjugated mAb against CD3 (HIT 3a), FITC-conjugated mAb against
CD4 (OKT4) (eBioscience), APC-conjugated mAb against CD8 (RPA-T8),
and PE-Cy™5 Mouse Anti-Human CD25 (M-A251) (BD Biosciences),
were used. To analyze the population of granuloma-involved T cells, after
removing supernatant from each well, weakly adherent cellular aggregates
were detached from the well and stained with the antibodies. Surrounding T
cells, not involved in granuloma formation, were collected from supernatant
of each sample and stained. The samples were analyzed using BD LSR
Fortessa and data analysis was done using FlowJo software (BD
Biosciences).
Annexin V and 7-amino-actinomycin D (7-AAD) staining for flow
cytometry
To determine cell viability and death by apoptosis or necrosis, collected
PBMCs were washed and then stained with Annexin V FITC (BD
Biosciences) and 7-AAD (eBioscience) for 15 min. For maximum
sensitivity, cells were analyzed 30 min after the staining by using BD
LSR Fortessa (BD Biosciences).
Statistics
Statistical analysis was performed using the Student’s t-test or ANOVA in
GraphPad Prism 5 software (GraphPad, La Jolla, CA, USA). The results
were shown as the means with standard deviation (s.d.). Significant
difference was defined by a value of P<0.05.
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